Two Sigma Investments
AGIO icon

Two Sigma Investments’s Agios Pharmaceuticals AGIO Stock Holding History

Two Sigma Investments’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,000
Closed -$200K – 3049
2017
Q3 		$200K Buy
+3,000
New +$180K ﹤0.01% 2592

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Two Sigma Investments's AGIO Position: Q1 2026 in Review

Two Sigma Investments reduced its Agios Pharmaceuticals (AGIO) stake by 16% in Q1 2026, selling an estimated $1.38M and leaving 251,636 shares worth $8.51M. The position accounts for 0.01% of the portfolio, ranked #1525.

Two Sigma Investments first reported a position in AGIO in Q2 2015 and has held it in 16 quarters since. The position peaked at $12.5M in Q2 2018. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Two Sigma Investments held 251,636 shares of Agios Pharmaceuticals worth $8.51M as of Q1 2026.
  • Two Sigma Investments sold 48,520 Agios Pharmaceuticals shares in Q1 2026, an estimated $1.38M.
  • Agios Pharmaceuticals made up 0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1525 holding.
  • Two Sigma Investments first reported a position in Agios Pharmaceuticals in Q2 2015 and has held it in 16 quarters since.
  • Two Sigma Investments's Agios Pharmaceuticals position peaked at $12.5M in Q2 2018.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.